1,944,221 research outputs found
BJM's birth story
No full text From spotting a gap in the market, to leading it, Mark Allen recalls how British Journal of Midwifery was born </jats:p
Mark Allen Greise
No full textMark Allen Griese, son of Mr. and Mrs. Don Griese, passed his first year milestone
Photograph of Mark Allen and interviewee
No full textColor photographs. UTRGV CHAPS graduate student, Mark Allen, and interviewee.https://scholarworks.utrgv.edu/chapsatwood/1021/thumbnail.jp
Photograph of Mark Allen and interviewee
No full textColor photographs. UTRGV CHAPS graduate student, Mark Allen, and interviewee.https://scholarworks.utrgv.edu/chapsatwood/1020/thumbnail.jp
Mark Allen : Distinguished Achievement Award - Education
Full text linkMark Allen \u2774 won the Distinguished Achievement Award - Education award in 2005, his bio is archived here from the SNC website
Systolic blood pressure and outcomes in frail older adults
Full text linkThis is the author accepted manuscript. The final version is available from Mark Allen Healthcare via the DOI un this recordHypertension is diagnosed in the majority of older people with frailty, in whom blood pressure prognosis is not well understood. This editorial describes recent evidence on blood pressure and outcomes in older people with frailty.National Institute for Health Research (NIHR
The integration of BRCA testing into oncology clinics.
No full textPURPOSE: The PARP inhibitor, Olaparib, is approved for women with BRCA-mutated ovarian cancer. Therefore there is an urgent need to test patients and obtain results in time to influence treatment. Models of BRCA testing, such as the mainstreaming oncogenetic pathway, involving oncology health professionals are being used. The authors report on the establishment of the extended role of the clinical nurse specialist in consenting women for BRCA testing in routine gynaecology-oncology clinics using the mainstreaming model. METHODS: Nurses undertook generic consent training and specific counselling training for BRCA testing in the form of a series of online videos, written materials and checklists before obtaining approval to consent patients for germline BRCA1 and BRCA2 mutations. RESULTS: Between July 2013 and December 2015, 108 women with ovarian cancer were counselled and consented by nurses in the medical oncology clinics at a single centre (The Royal Marsden, UK). This represented 36% of all ovarian cancer patients offered BRCA testing in the oncology clinics at the centre. Feedback from patients and nurses was encouraging with no significant issues raised in the counselling and consenting process. CONCLUSION: The mainstreaming model allows for greater access to BRCA testing for ovarian cancer patients, many of whom may benefit from personalised therapy (PARP inhibitors). This is the first report of oncology nurses in the BRCA testing pathway. Specialist oncology nurses trained in BRCA testing have an important role within a multidisciplinary team counselling and consenting patients to undergo BRCA testing
Vitamin D supplementation and clinical outcomes in cancer survivorship
No full textIncreasing evidence points to the role of vitamin D supplementation in cancer management. A comprehensive search of online databases was undertaken for all research studies relating to vitamin D supplementation in cancer survivorship published up to November 2017. Eighteen studies meeting the inclusion criteria were selected for this review, the majority of which involved supplementation in breast cancer. This review concludes that vitamin D supplementation plays an important role in disease-free survival in a number of cancers, particularly breast. In other cancers, the role of supplementation is less clear, and more research is required. More research is also required to investigate the most effective dose and duration of vitamin D supplementation to benefit cancer survivors.2019-04-2
Multiple myeloma: managing a complex blood cancer
No full textThis article gives a comprehensive overview of multiple myeloma (MM), a complex blood cancer involving overproduction of plasma cells. Although MM remains incurable, patients are living longer as a result of multiple treatment options. However, MM patients are also living with a higher symptom burden. The overall aims in managing MM are therefore to control disease progression, prolong survival and improve quality of life
- …
